Key facts
- Flowbio’s last known valuation is $5.8M (Feb 2025).
- It has raised $4.3M across 2 recorded rounds; the latest was Later Stage VC ($1.3M) in Feb 2025.
- Notable investors include Innovate UK, SOSV, Metaplanet Holdings, Entrepreneurs First, HAX — 15 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Flowbio
Funding rounds
2 roundsAbout Flowbio
Developer of a real-time hydration sensor designed to monitor human bodies at a molecular level. The company's tool is a wearable, non-invasive patch that captures an athlete's sweat and interprets key bio-markers in real-time, starting with electrolytes and total body fluid loss, enabling users to get personalized recommendations that help them improve their performance.
- Industry
- Electronics (B2C)
- Sector
- Consumer Products and Services (B2C)
- HQ
- London, United Kingdom
- Founded
- 2020
- Employees
- 14
- Website
- flowbio.com/
- Ownership
- Privately Held (backing)
Flowbio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Flowbio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Flowbio in its N-PORT filings yet. We sweep new filings monthly.